Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Effects of BNP in Hypertensive Patients
NCT02608996Phase 2Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nesiritide in hypertension (HTN), sponsored by Oslo University Hospital. Started Dec 2015; status: recruiting.
02
Drugs
nesiritide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02608996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608996.